Resistance Training as a Cognitive Intervention: The Myokine Argument

Resistance training produces cognitive benefits through a mechanism that is biologically distinct from aerobic exercise. Both modalities raise BDNF acutely. Both improve cerebrovascular function chronically. But resistance training specifically activates the muscle-as-endocrine-organ pathway — releasing myokines (irisin, cathepsin B, IL-6, FGF-21, BDNF itself) into circulation, where they cross the blood-brain barrier and exert independent neuroprotective effects.

The cognitive longevity literature has historically emphasized aerobic exercise. The aerobic data is robust. But the resistance-specific data — from the SPRINT-MIND trial extensions, the Mavros et al. SMART trial, the Liu-Ambrose work in older adults, and the broader myokine literature — has accumulated to the point that any serious cognitive longevity protocol should include progressive resistance training as a distinct intervention, not a substitute or afterthought to aerobic.

What follows: the myokine pathway, the trial data on resistance training and cognitive endpoints, the IGF-1 mechanism, the dose-response that matters, and the practical protocol that translates the published evidence into a sustainable training program.

Myokines — The Muscle-Brain Endocrine Pathway

The concept of muscle as an endocrine organ emerged in the early 2000s when Bente Pedersen's group at the Centre for Inflammation and Metabolism in Copenhagen identified that contracting skeletal muscle releases peptides — myokines — that act systemically rather than locally. Over the past two decades, hundreds of myokines have been characterized. A small subset have demonstrated brain-relevant activity at physiological circulating concentrations.

Irisin was identified by Bruce Spiegelman's lab at Harvard in 2012. Released from muscle in response to exercise, it crosses the blood-brain barrier and acts on the hippocampus and dentate gyrus — the brain regions implicated in memory consolidation and adult neurogenesis. Animal studies have shown that irisin administration improves spatial learning and memory in models of Alzheimer's disease, and that blocking irisin abolishes the cognitive benefit of exercise. Human serum irisin rises in response to both aerobic and resistance training, with some evidence of a stronger acute response to high-intensity resistance work.

Cathepsin B was characterized by the Sanjay Gupta lab at Korea University in 2014. It is released from muscle during exercise, crosses into the brain, and directly stimulates BDNF expression and adult hippocampal neurogenesis. Mice deficient in cathepsin B do not show the exercise-mediated cognitive improvement that wild-type mice show — establishing cathepsin B as a necessary mediator of the exercise-cognition link in animal models. Human serum cathepsin B rises in response to exercise, with the literature still developing on the resistance-versus-aerobic comparison.

Interleukin-6 (IL-6) is the most-studied myokine, with a paradoxical biology — chronically elevated IL-6 in the absence of exercise is a marker of systemic inflammation and predicts adverse cognitive outcomes, while exercise-induced acute IL-6 release exerts anti-inflammatory effects via downstream IL-10 induction. The resistance training literature shows particularly robust acute IL-6 elevations, with the chronic anti-inflammatory effects accumulating across training programs.

FGF-21 is released from muscle in response to exercise and from liver in response to fasting and ketogenic states. It crosses the blood-brain barrier and improves insulin sensitivity, energy expenditure regulation, and (in animal models) cognitive function. The mechanism is metabolic — FGF-21 shifts brain energy substrate availability in directions that support cognitive performance.

Muscle-derived BDNF. The same protein characterized in the brain is also produced in skeletal muscle and released into circulation during exercise. Whether muscle-derived BDNF reaches the brain in physiologically meaningful concentrations remains debated, but the integrated muscle-brain BDNF response to exercise is one of the larger cognitive-relevant signals in the broader literature.

The Resistance-Specific Trial Data

The cognitive-longevity literature on resistance training has emerged primarily from three lines of investigation.

SMART trial (Mavros et al., 2017). Published in JAGS. 100 older adults aged 55–86 with mild cognitive impairment, randomized to 6 months of supervised progressive resistance training versus active control. The resistance training group showed significant improvements on the ADAS-Cog composite cognitive endpoint compared to controls. The 18-month follow-up showed that the cognitive benefit was largely maintained even after the supervised training program ended. The trial established that progressive resistance training, at intensity (not just "active exercise"), produces measurable cognitive benefit in adults already at elevated dementia risk.

Liu-Ambrose work at UBC. A series of RCTs from the Aging, Mobility and Cognitive Neuroscience Lab established that once-weekly and twice-weekly resistance training in adults aged 65–75 produces improvements in executive function and attention compared to balance-and-tone control. The dose-response data identified twice-weekly as the threshold producing reliable cognitive benefit, with neuroimaging follow-up showing changes in regional brain volume in the trained group.

SPRINT-MIND adjacent literature. The main SPRINT-MIND trial (Williamson et al., 2019) established that intensive blood pressure lowering reduced the combined risk of mild cognitive impairment and probable dementia. The mechanism — improved cerebrovascular function — is one of the same mechanisms resistance training exerts. Subsequent analyses have positioned resistance training as a non-pharmacological lever for the same cardiovascular-cognitive coupling that SPRINT-MIND identified pharmacologically.

The integration across these three lines: resistance training at sufficient intensity, performed at least twice weekly, produces measurable cognitive benefit in older adults across cognitive endpoints — executive function, processing speed, and memory consolidation. The effect sizes are smaller than the integrated multi-domain FINGER protocol, but they are independent of aerobic exercise and additive to it.

IGF-1 — The Insulin-Like Growth Factor Pathway

Insulin-like growth factor 1 (IGF-1) is a hormone released primarily by the liver in response to growth hormone but also produced locally in muscle in response to resistance training. It crosses the blood-brain barrier and acts on hippocampal neurons to promote dendritic branching, synaptic density, and adult neurogenesis. Serum IGF-1 falls with age, and the rate of decline is steeper in sedentary populations.

The cognitive-protective role of IGF-1 is nuanced. Lifelong high IGF-1 is associated with increased cancer risk (the basis of the caloric restriction longevity protocols). But age-related IGF-1 decline is also associated with cognitive impairment and frailty. The pragmatic interpretation that has emerged: maintaining IGF-1 in the middle range — not the highest tertile, not the lowest — appears protective for both cognitive function and broader healthspan endpoints. Resistance training is one of the primary non-pharmacological levers for elevating IGF-1 in adults whose levels have fallen with age.

The mechanistic link to BDNF is established. IGF-1 acts on hippocampal neurons in part by potentiating BDNF signaling. The two pathways converge on the same neuroprotective downstream targets — synaptic strengthening, neurogenesis, executive function support.

The Dose-Response: Intensity Matters More Than Duration

The cognitive-specific resistance training literature has converged on a small set of dose parameters:

Frequency. Twice weekly is the threshold the Liu-Ambrose work identified as producing reliable cognitive benefit. Three sessions weekly produces additional benefit on some endpoints. Single weekly sessions are below the threshold for the cognitive-specific signal — though they still produce strength and sarcopenia benefits.

Intensity. Progressive overload at 70–85 percent of 1-rep maximum is the load range that produces the strongest myokine response and the most consistent cognitive endpoint improvements. Light "resistance band" training that does not approach near-maximal load produces meaningfully smaller signals. The cognitive cohort effect of resistance training in the published literature is concentrated in adults who actually train at intensity.

Volume. 3–4 sets of 6–10 repetitions per major movement is the rep range most commonly used in the supportive trial protocols. The total weekly volume per major muscle group falls in the 8–16 working sets range — high enough to drive myokine response, not so high as to require pharmacological recovery support.

Movement selection. Multi-joint compound movements — squats, deadlifts, presses, pulls — produce the largest hormonal and myokine response per unit of training time compared to isolation work. The cognitive-cohort training programs are built around compound movements at intensity, with isolation work as auxiliary if at all.

Progression. The cognitive benefit is specifically tied to progressive overload — the training program needs to increase load, reps, or both over time as adaptation occurs. Static "maintenance" resistance training produces meaningfully smaller cognitive benefits than progressive programs.

The Aerobic-Versus-Resistance Question — Both, Not Either

The historical framing of "cardio versus weights" misrepresents the underlying biology. The cognitive longevity protocol the current literature supports includes both, because they activate partially distinct pathways.

Aerobic exercise produces the largest acute BDNF response, the strongest cerebrovascular adaptations, and the most robust mitochondrial improvements. Zone 2 work specifically drives mitochondrial density and the metabolic flexibility that supports cognitive function. Higher-intensity intervals (above lactate threshold) drive the strongest BDNF spikes.

Resistance training produces the largest myokine response, the strongest IGF-1 elevation, and the most direct muscle-derived endocrine signaling. It builds and maintains the lean tissue mass that underlies metabolic health, glucose disposal, and the muscle-as-endocrine-organ pathway that exerts independent cognitive-protective effects.

The integrated protocol most often recommended by the cognitive-longevity-focused clinicians (Attia, Galpin, Lyon, Means):

• 2–3 sessions per week of progressive resistance training. Compound movements at 70–85 percent of 1RM, 3–4 working sets per major muscle group, with progressive overload tracked across training cycles.
• 3–4 sessions per week of Zone 2 aerobic work. 45–60 minutes at the intensity where lactate begins to accumulate (typically 60–70 percent of max heart rate for trained adults, lower for sedentary). This drives mitochondrial adaptation.
• 1–2 sessions per week of higher-intensity aerobic work. Intervals above lactate threshold. These drive the strongest acute BDNF response and the VO2 max improvements that predict lifespan independent of other cardiovascular markers.
• Daily movement outside structured training — walking, mobility, low-intensity activity. The non-exercise activity thermogenesis (NEAT) contribution to overall metabolic health is non-trivial.

This integrated protocol is consistent with what the FINGER trial used as its exercise pillar — aerobic plus resistance, supervised, progressive. It is the protocol the SMART trial used. It is the protocol the SPRINT-MIND cognitive arm implicitly assumes through its cardiovascular risk management approach.

The Practical Implementation

The published trial protocols are uniformly supervised. Home or unsupervised programs work, but the cognitive-cohort effect depends heavily on the adult actually training at intensity with progressive overload — and supervision is one of the strongest predictors of whether that happens in practice.

For adults building this into a routine without trainer supervision, the practical compromise: pick three compound movements (a lower-body push like squats, a hinge like deadlifts or RDLs, an upper-body push or pull). Train twice weekly. Track the working sets and the load. Progress the load when 3 sets of 8 becomes accessible — add 2.5–5 lbs and repeat. This is the simplest sustainable protocol that hits the cognitive-relevant dose parameters without requiring sophisticated programming.

The recovery side matters. Resistance training imposes a recovery cost the cognitive benefit depends on the body resolving. Adequate sleep (the same architecture that drives glymphatic clearance), adequate protein intake (typically 1.6–2.2 g per kg of bodyweight daily for adults targeting cognitive-relevant lean mass maintenance), and the nutritional environment the MIND-pattern protocol supports are all necessary supports for the training stimulus to produce its cognitive return.

The Longevity Strength System covers the full progressive resistance training protocol — the movement selection, the loading scheme, the progression schedule, and the recovery architecture — for adults building this into a cognitive longevity routine. The Mediterranean Stack covers the dietary support layer that the training stimulus requires. The supplement layer that supports the muscle-side mechanisms: Marine Collagen Peptides Pro for the connective tissue load resistance training places on tendons and ligaments, and NMN + Resveratrol Complex for the NAD+ substrate the mitochondrial demand of training relies on.

Resistance training is the single intervention that addresses cognitive, metabolic, sarcopenic, glycemic, and bone-density endpoints simultaneously through partially distinct biological pathways. The cognitive layer is one component of a much broader case. The published evidence supports it. The protocol requires effort. The return on that effort, in cognitive function preserved into the eighth and ninth decades of life, is the highest-leverage available.

This article is part of the PureLongevity research library. Nothing here constitutes medical advice. The training interventions described are research-supported but require individual calibration with a qualified coach or clinician — particularly for adults new to resistance training or with established cardiovascular disease, joint pathology, or osteoporosis. PureLongevityToday may earn a commission from purchases made through links in this article.